1. Contractors
  2. Ortho-Clinical Diagnostics Gmbh

Ortho-Clinical Diagnostics Gmbh

Federal contractor · In-Vitro Diagnostic Substance Manufacturing

Ortho-Clinical Diagnostics Gmbh has 5 federal contracts of $100,000 or more active since October 2023, with $1M obligated, from 3 agencies. None is running now.

Contracts
5 since FY2024$1,003,231 obligated, contracts of $100,000 or more
Running now
None2 ended in the last 12 months
Biggest customer
Defense Health Agency$493K on 3 contracts
UEI
GM5SLSX6DLH5Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$345,763
FY2021$135,767
FY2024$164,198
FY2025$179,272
FY2026$178,232

Running contracts

No contract of $100,000 or more is running now.

Who they work for

AgencyAmount
Defense Health Agency3 contracts$493,270
Department of the Air Force1 contract$345,763
Department of the Army1 contract$164,198

What they sell

IndustryAmount
In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 2 contracts$357,504
Analytical Laboratory Instrument ManufacturingNAICS 334516 · 1 contract$345,763
Medical LaboratoriesNAICS 621511 · 1 contract$164,198
Surgical and Medical Instrument ManufacturingNAICS 339112 · 1 contract$135,767

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Defense Health Agency: see the list.

Get new notices like Ortho-Clinical Diagnostics Gmbh's work

New contract opportunities under NAICS 325413, in-vitro diagnostic substance manufacturing, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy